Aegon Ltd. vs Alcon AG — how do they compare? Aegon Ltd. trades at $9.45 (market cap $14.01B), while Alcon AG trades at $72.57 (market cap $36.44B). The key difference: Alcon AG is far larger — about 2.6× Aegon Ltd.'s market cap, and Aegon Ltd. pays the higher dividend (4.94%). Which is the better fit depends on your goals.
| AEG | ALC | |
|---|---|---|
Market Cap | $14.01B | $36.44B |
Sector | Financials | Health |
52-Week High | $9.53 | $90.12 |
52-Week Low | $6.79 | $62.02 |
Enterprise Value | $15.16B | $40.28B |
Dividend Yield | 4.94% | 0.48% |
Trailing returns across standard periods
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →